The third round of national collection is about to begin

News came out, the third round of production procurement is not day or will start toaccording to industry sources, 15 Shanghai Pharmaceutical Centralized Tender procurement management meeting, the content of the meeting is mainly related to the national collection-related work, previously responsible for the national collection work related to the participation of the relevant peoplesome analysts pointed out that the convening of this meeting may indicate that a new round of collection has entered the preparatory stageAccording to the previous experience, the collection will generally experience the convening of internal meetings of relevant departments, business symposiums and other non-public links, after full discussion and communication between the government and enterprises to enter the confirmation collection list, formal bidding and procurement and other open linksother industry insiders said that before the Shanghai meeting, the National Health Insurance Administration in Beijing has held a collection of related meetings, it seems that the next stage may be carried out to the part of enterprise participationin addition, the Shanghai meeting also discussed the procurement of high-value consumables with volume, has been in the provinces statistics, is expected to be included in the third batch of national collection before the collection of some high-value consumables for collectionJust a few days ago, Fujian and other provinces for high-value supplies collection documents have been publishedaccording to the national 2020 pharmaceutical recruitment documents, the relevant departments will strengthen the consistency of evaluation of drug competitive situation analysis, research and put forward suitable for centralized procurement of products and product characteristics analysisas to the start of the third round of collection time, the former Zhejiang Province Pharmaceutical Industry Association President Guo Taihong to The Cypress Blue analysis, the next batch of volume procurement will certainly be carried out, originally expected to start in the first half of the year, but because the outbreak may be delayed for some timeaffected by the outbreak, the supply of selected varieties from some of the second batch of band purchases was delayed until JuneAccording to the Shanghai Sunshine Pharmaceutical Procurement Network on April 10 issued a work tip, affected by the outbreak, the second batch of national collection of 32 varieties, Omesatan tablets, Anlisheng tan tablets, polyglycol 4000 dispersal, hydrochloric acid left-sitili tablets in the initial stage of the implementation of the four varieties may be tight supply, delivery delays and other issues, of which Omesatan ester is expected to gradually restore production capacity in June, normal supplythe National Health Insurance Administration issued a previous letter urging the provinces in April to do a good job in the second batch of load purchase results landing work, taking into account the epidemic factors, if the winning enterprise slated supply difficulties, can negotiate the delay of supply, but no later than JuneIf June is the second round of the winning enterprise to restore product supply and the second round of belt quantity procurement results of the latest time to land in full, according to the previous law, the previous round of collection after the full landing, the next round of collection may begin, some people believe that perhaps July will startfrom the first round of 4 plus 7 band volume procurement to the second round of national collection, we can see that the time interval of the collection and promotion is gradually shortened, the situation of accelerated collection is obviousthe first round of the 4 plus 7 sets of december 2018 results, the following year february-March, the first 25 varieties of procurement expanded to the whole country, the second round of collection, the results in January 2020, in April into the procurement phaseHaitong Securities in the research report "Deer-by-Deer China - cross-border pharmaceutical enterprises and local drug companies competition" analysis pointed out that the large probability of the volume of procurement is mainly sample hospital Top100 best-selling drugs, and has been evaluated manufacturers of varieties, because according to the instructions of the Health Insurance Bureau, best-selling varieties are more likely to be included in the band procurement;Ping An Securities expects that after the outbreak of the new crown, the third round of national collection will be launched quickly, over-rated enterprises, the variety of 3 into the probability is greater , an industry authority who did not want to be named, told Cypress Blue that a new round of strapping purchases could push through the boundaries of consistency evaluation, health insurance catalogs, drugs and supplies Guo Taihong, a , said the use of large, high prices, there is room for decline in the collection of uncollected drugs may be included in the collection In addition, the collection of non-medicy varieties is also possible, but will not become the focus of collection Haitong Securities analysis pointed out that from the number of winning varieties of enterprises can be seen, the amount of procurement to the head of the concentration of domestic capital Historical data prove that multinational pharmaceutical companies in the future to deal with the band procurement will become more active, with mature drugs to participate in a new round of band procurement may be the focus of multinational pharmaceutical enterprises at this stage if no accident, then, the domestic head drug companies and multinational drug companies between the deer will be more intense.